Sites

Together we put patients first

As one of the most important contributors to the clinical development ecosystem, clinical research sites are uniquely positioned to meet patients where they are and help connect them with new treatment opportunities. By working with Parexel your first-hand patient insights, therapeutic area knowledge, and clinical expertise will help bring new therapies to patients sooner, supported every step of the way by our world-class clinical research team.

Why participate in clinical trials?

Every clinical trial begins with a patient and the healthcare professionals committed to improving lives.  As a physician, clinical investigator or research site, you play a vital role in advancing medical innovation, expanding treatment options, and helping bring new therapies to patients with unmet needs. At Parexel, we are committed to making research participation easier through strong site partnerships, responsive support, and a shared focus on delivering better outcomes for patients worldwide.
Benefits for your patients, your practice, and you:

  • Provide your patients with access to novel biopharmaceuticals
  • Offer additional treatment options for patients with unmet medical needs
  • Contribute to advancing medical science and improving future standards of care
  • Expand your research capabilities and create new opportunities for your practice
  • Stay at the forefront of emerging scientific and therapeutic developments

 

 

Do you want to be considered for studies managed by Parexel? 

Create (or update) your  detailed site profile to be considered for any future clinical studies in your therapeutic areas of expertise.  

Create your site profile

 

Why work with us?

Successful clinical research depends on strong site partnerships. At Parexel, we are committed to building collaborative, responsive relationships that help sites deliver high-quality research while focusing on what matters most: patients.

When you work with Parexel, you benefit from:

  • Patient-focused therapies that deliver meaningful benefits early in development and include patient insights at every step
  • Dedicated study teams committed to proactive communication and site support
  • A global footprint that brings local knowledge and support to your geographic region 
  • A long-standing commitment to understanding and addressing site needs and improving your study experience 
  • Access to Phase I-IV clinical trial opportunities across a wide variety of therapeutic areas

Parexel covers a breadth of indications in these therapeutic areas:

 

Parexel also works in these cross-therapeutic areas

Our commitment to emerging sites

Through a one-year scholarship program, Parexel is supporting emerging investigative sites—the next generation of clinical research sites — with support and resources to help them reach the next level. 

Emerging Site Scholarship winners receive: 

  • A one-year membership to SCRS with access to online training resources and toolkits.
  • Two mentor sessions with an experienced investigative site from our Site Alliance Program to help you navigate some of your biggest challenges.
  • A dedicated Parexel Site Alliance Manager (SAM) who will be assigned to you for one year and hold bi-monthly meetings. The SAM will train your team on what a good site looks like to CROs and sponsors, how to navigate the feasibility process, and organize meetings with different Parexel functions.
  • One complimentary registration pass to either the next SCRS Global Site Solutions Summit or the SCRS European Site Solutions Summit. 

Check back for updates on our next Emerging Site Scholarship call for applications (Spring 2027). 

Recognized by Sites for Excellence in Partnership

Parexel's commitment to strong site relationships, collaboration, and operational excellence has been consistently recognized by the global research community.

Consecutive SCRS Eagle Award Winner (2023 and 2024)

Parexel was honored with the Society for Clinical Research Sites (SCRS) Eagle Award in both 2023 and 2024. Voted on by the global site community, the Eagle Award recognizes CROs that demonstrate outstanding leadership, professionalism, integrity, passion, and dedication to advancing clinical research through exceptional site partnerships.

This consecutive recognition reflects our ongoing commitment to listening to sites, reducing site burden, and fostering collaborative relationships that help studies succeed.

WCG CenterWatch Top CRO to Work With

Parexel was rated “Top CRO to Work With” in the 2023 WCG CenterWatch Global Site Relationship Benchmark Survey. Among the 34 CROs included in the survey, Parexel received the highest average rating across all 26 performance attributes evaluated. In addition, Parexel ranked highest on four out of the five attributes considered the most important to investigative sites and was selected as the CRO that investigative sites were most willing to recommend to a colleague. The strong rating follows Parexel’s “Top CRO to Work With” rating in the 2021 WCG CenterWatch Global Site Relationship Benchmark Survey, the most recent survey conducted prior to 2023.

“Best Contract Research Organization” at 21st Annual Scrip Awards

Parexel was named “Best Contract Research Organization” in the Full-Service Provider category at the 21st annual Scrip Awards. This honor recognizes Parexel’s continued excellence in partnering with biopharma companies to design, drive and execute all aspects of clinical trials as well as the company’s vital contributions to drug development, patient impact and global public health.